Rasera Irineu, Luque Alexandre, Junqueira Silvio Mauro, Brasil Níssia Capello, Andrade Priscila Caldeira
Bariatric Surgery, Clínica Bariátrica, Hospital dos Fornecedores de Cana de Piracicaba, Piracicaba, Brazil.
HEMA Brazil, Johnson & Johnson Medical Devices Brazil, Rua gerivatiba, 207, 12 andar, Butantã, São Paulo, SP, Brazil.
Obes Surg. 2017 Feb;27(2):536-540. doi: 10.1007/s11695-016-2439-y.
This study aimed to evaluate the waiting time, safety, and effectiveness of bariatric surgery based on real-world data.
This is a noninterventional, noncomparative, and retrospective study with 300 morbidly obese patients who had undergone open Roux-en-Y surgery.
The procedure was found to be very safe, with low rates of overall complications (10.7%). Approximately 48.4% of the patients had reached a BMI <30 mg/kg at 12 months after surgery, while 6% were still classified as morbidly obese (BMI >40 mg/kg). Comorbidity resolution was over 90% for all conditions, except for cardiovascular disease, which showed a 40% resolution. The mean number of drugs taken also decreased at 12 months after surgery.
Bariatric surgery was found to be effective in weight reduction and in the resolution of comorbidities.
本研究旨在基于真实世界数据评估减肥手术的等待时间、安全性和有效性。
这是一项针对300例接受开放式Roux-en-Y手术的病态肥胖患者的非干预性、非对比性回顾性研究。
该手术被发现非常安全,总体并发症发生率较低(10.7%)。约48.4%的患者在术后12个月时BMI降至<30mg/kg,而6%的患者仍被归类为病态肥胖(BMI>40mg/kg)。除心血管疾病的缓解率为40%外,所有疾病的合并症缓解率均超过90%。术后12个月时服用药物的平均数量也有所减少。
减肥手术在减轻体重和解决合并症方面被发现是有效的。